Literature DB >> 27060811

Short communication: Differential loss of bovine mammary epithelial barrier integrity in response to lipopolysaccharide and lipoteichoic acid.

Olga Wellnitz1, Christina Zbinden2, Xiao Huang3, Rupert M Bruckmaier4.   

Abstract

In the mammary gland, the blood-milk barrier prevents an uncontrolled intermixture of blood and milk constituents and hence maintains the osmotic gradient to draw water into the mammary secretion. During mastitis, the permeability of the blood-milk barrier is increased, which is reflected by the transfer of blood constituents into milk and vice versa. In this study, we aimed to investigate changes in the barrier function of mammary epithelial cells in vitro as induced by cell wall components of different pathogens. Primary bovine mammary epithelial cells from 3 different cows were grown separately on Transwell (Corning Inc., Corning, NY) inserts. The formation of tight junctions between adjacent epithelial cells was shown by transmission electron microscopy and by immunofluorescence staining of the tight junction protein zona occludens-1. The integrity of the epithelial barrier was assayed by means of transepithelial electrical resistance, as well as by diffusion of the fluorophore Lucifer yellow across the cell layer. The release of lactate dehydrogenase (LDH) was used as an indicator for cytotoxic effects. In response to a 24-h challenge with bacterial endotoxin, barrier integrity was reduced after 3 or 7h, respectively, in response to 0.5mg/mL lipopolysaccharide (LPS) from Escherichia coli or 20mg/mL lipoteichoic acid (LTA) from Staphylococcus aureus. No paracellular leakage was observed in response to 0.2mg/mL LPS or 2mg/mL LTA. Although LPS and LTA affected barrier permeability, most likely by opening the tight junctions, only LPS caused cell damage, reflected by increased LDH concentrations in cell culture medium. These results prove a pathogen-specific loss of blood-milk barrier integrity during mastitis, which is characterized by tight junction opening by both LPS and LTA and by additional epithelial cell destruction through LPS.
Copyright © 2016 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blood–milk barrier; mammary; mastitis; tight junction

Mesh:

Substances:

Year:  2016        PMID: 27060811     DOI: 10.3168/jds.2016-10927

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  6 in total

1.  Selected reaction monitoring mass spectrometry of mastitis milk reveals pathogen-specific regulation of bovine host response proteins.

Authors:  Ulrike Kusebauch; Lorenzo E Hernández-Castellano; Stine L Bislev; Robert L Moritz; Christine M Røntved; Emøke Bendixen
Journal:  J Dairy Sci       Date:  2018-04-11       Impact factor: 4.034

Review 2.  TRIENNIAL LACTATION SYMPOSIUM/BOLFA: Pathogen-specific immune response and changes in the blood-milk barrier of the bovine mammary gland.

Authors:  R M Bruckmaier; O Wellnitz
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

Review 3.  Targeting gut microbiota as a possible therapy for mastitis.

Authors:  Xiaoyu Hu; Shumin Li; Yunhe Fu; Naisheng Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-05-11       Impact factor: 3.267

4.  The gut microbiota contributes to the development of Staphylococcus aureus-induced mastitis in mice.

Authors:  Xiaoyu Hu; Jian Guo; Caijun Zhao; Peng Jiang; T Maimai; Li Yanyi; Yongguo Cao; Yunhe Fu; Naisheng Zhang
Journal:  ISME J       Date:  2020-04-27       Impact factor: 10.302

5.  Immune cell counts and signaling in body fluids of cows vaccinated against Clostridium difficile.

Authors:  Christiane Schmautz; Nadine Müller; Marlene Auer; Ines Ballweg; Michael W Pfaffl; Heike Kliem
Journal:  J Biol Res (Thessalon)       Date:  2018-12-10       Impact factor: 1.889

6.  Effect of the Ketone Body Beta-Hydroxybutyrate on the Innate Defense Capability of Primary Bovine Mammary Epithelial Cells.

Authors:  Maria Hillreiner; Claudia Flinspach; Michael W Pfaffl; Heike Kliem
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.